• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Canada’s Inversago raises $7M to target cannabinoid receptors fiercepharma
    July 30, 2018
    Inversago Pharma reeled in a $7 million series A round to move a suite of next-generation cannabinoid receptor-1 (CB1) blockers into the clinic. The Montreal-based startup is developing the drugs for Prader-Willi syndrome, as well as metabolic disorders i

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service